<img alt="" src="https://secure.perk0mean.com/184386.png" style="display:none;">

Pharmaceutical Supply Chain & Distribution Center Contingencies During COVID-19:
Collaborative Learning Q&A

Listen to a Q&A with Patrick Girten Manager, Quality Distribution US/PR, Bristol Myers Squibb, & Michael Hollweck, Senior Manager QA Logistics Americas, Celgene about how their supply chains were affected by COVID-19, including:

  • Precautionary DC operations during COVID
  • Creating redundancy in distribution with secondary sites and logistics providers
  • Approving new contingency routes
  • Shipping cross borders and customs
  • Virtual auditsis this a viable future for pharmaceutical QA supply chains?
Thumbnail_Pharmaceutical Supply Chain & Distribution Center Contingencies During COVID-19_EN